Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POSA-FLU: Posaconazole Prophylaxis for IAA
NCT03378479Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Dec 2017
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of posaconazole in Invasive Pulmonary Aspergillosis (IPA), sponsored by UZ Leuven. Started Dec 2017; status: completed.
02
Drugs
posaconazole
03
Conditions
Invasive Pulmonary Aspergillosis (IPA)
Beyond the preview
Go deeper on NCT03378479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03378479.